Roivant Sciences Ltd.

ROIV chart

Roivant Sciences Ltd. news

• Roivant Sciences (ROIV) Q2 2026 Earnings Call Transcript

  fool.com · Nov 9, 5:13 PM EST

• Roivant Sciences Q2 Earnings Call Highlights

  marketbeat.com · Nov 9, 12:15 PM EST

• Tranche Update on Roivant Sciences Ltd.'s Equity Buyback Plan announced on August 11, 2025.

  marketscreener.com · Nov 9, 11:51 AM EST

• Roivant Sciences Ltd reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 9, 9:31 AM EST

• Roivant Sciences Q2 2027 Earnings Call Transcript

  Benzinga · Nov 9, 9:08 AM EST

• Earnings call transcript: Roivant Sciences tops Q2 2026 estimates on LISRAYA launch

  Investing.com UK · Nov 9, 9:00 AM EST

• Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026

  www.marketscreener.com · Nov 9, 8:50 AM EST

• Roivant Sciences Reports Q2 2026 Revenue of $35.1 Million, EPS L

  GuruFocus · Nov 9, 8:36 AM EST

• Roivant Sciences earnings beat by $0.10, revenue topped estimates

  Investing.com · Nov 9, 8:21 AM EST

• Roivant Sciences Q2 2026: LISRAYA Launch Beats Expectations

  24/7 Wall St. · Nov 9, 7:46 AM EST

• Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Tops Revenue Estimates

  Yahoo Finance · Nov 9, 7:40 AM EST

• Revenue reaches $35.1M at Roivant Sciences (ROIV), but the quarterly loss widens.

  Stock Titan · Nov 9, 7:37 AM EST

Roivant Sciences Ltd. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-09
• 8-K8-K2026-11-09
• 8-K8-K2026-10-21
• 8-K8-K2026-09-18
• 8-K8-K2026-09-08
• 8-K8-K2026-08-28
• 8-K8-K2026-08-27
• 10-Q10-Q2026-08-06
• 8-K8-K2026-08-06
• DEF 14ADEF 14A2026-07-29
• 10-K10-K2026-05-20
• 8-K8-K2026-05-20

About Roivant Sciences Ltd.

Ticker

ROIV (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

London

Incorporated in

Bermuda

Fiscal year end

March 31

SEC CIK

1635088

Frequently asked questions